Compare ACOG & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | SY |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.6M | 218.8M |
| IPO Year | 2024 | 2018 |
| Metric | ACOG | SY |
|---|---|---|
| Price | $8.80 | $2.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.00 | $5.50 |
| AVG Volume (30 Days) | 153.2K | ★ 646.8K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | ★ 41.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,220,275.00 | N/A |
| Revenue This Year | $139.22 | $38.64 |
| Revenue Next Year | $134.48 | $30.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $1.28 |
| 52 Week High | $10.14 | $4.75 |
| Indicator | ACOG | SY |
|---|---|---|
| Relative Strength Index (RSI) | 44.47 | 57.79 |
| Support Level | $7.50 | $2.53 |
| Resistance Level | $9.04 | $2.96 |
| Average True Range (ATR) | 0.51 | 0.19 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 13.91 | 46.79 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.